Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
Clinical trial NCT04252612 · WITHDRAWN
Trial details
- NCT number
- NCT04252612
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2023-06-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.